BZ371A

DRUG2 trials

Sponsors

Biozeus Biopharmaceutical S.A.

Conditions

Erectile DysfunctionErectile Dysfunction Following Radical ProstatectomyProstate CancerRadical Prostatectomy

Phase 1

Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered

CompletedNCT05332340

Biozeus Biopharmaceutical S.A.Erectile Dysfunction, Erectile Dysfunction Following Radical Prostatectomy, Prostate Cancer +1

Start: 2022-11-16End: 2022-11-30Updated: 2025-03-07

Phase 2

Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients

RecruitingNCT05558007

Biozeus Biopharmaceutical S.A.Erectile Dysfunction, Erectile Dysfunction Following Radical Prostatectomy, Prostate Cancer +1

Start: 2023-11-22End: 2025-01-31Target: 72Updated: 2024-10-22